Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Critical Illness | 73 | 2024 | 2703 | 10.910 |
Why?
|
Enteral Nutrition | 40 | 2024 | 785 | 10.100 |
Why?
|
Intensive Care Units, Pediatric | 54 | 2024 | 1014 | 7.980 |
Why?
|
Nutritional Support | 14 | 2021 | 172 | 5.300 |
Why?
|
Parenteral Nutrition | 26 | 2021 | 656 | 4.780 |
Why?
|
Nutritional Status | 32 | 2024 | 1607 | 4.420 |
Why?
|
Respiration, Artificial | 29 | 2023 | 2618 | 3.780 |
Why?
|
Calorimetry, Indirect | 20 | 2020 | 174 | 3.760 |
Why?
|
Energy Intake | 27 | 2023 | 2127 | 3.680 |
Why?
|
Dietary Proteins | 15 | 2018 | 949 | 2.780 |
Why?
|
Critical Care | 24 | 2024 | 2692 | 2.530 |
Why?
|
Energy Metabolism | 23 | 2023 | 2868 | 2.420 |
Why?
|
Nutrition Therapy | 5 | 2021 | 101 | 2.310 |
Why?
|
Nutritional Requirements | 13 | 2021 | 275 | 2.250 |
Why?
|
Nutrition Assessment | 13 | 2022 | 726 | 1.850 |
Why?
|
Pulmonary Gas Exchange | 6 | 2015 | 378 | 1.840 |
Why?
|
Basal Metabolism | 7 | 2016 | 161 | 1.790 |
Why?
|
Child | 107 | 2024 | 79813 | 1.750 |
Why?
|
Malnutrition | 11 | 2023 | 639 | 1.750 |
Why?
|
Oxygen Consumption | 7 | 2017 | 1846 | 1.660 |
Why?
|
Capnography | 3 | 2017 | 91 | 1.500 |
Why?
|
Peptic Ulcer | 2 | 2024 | 217 | 1.450 |
Why?
|
Carbon Dioxide | 7 | 2017 | 1146 | 1.430 |
Why?
|
Body Composition | 9 | 2020 | 2416 | 1.410 |
Why?
|
Gastric Emptying | 5 | 2021 | 242 | 1.370 |
Why?
|
Child Nutritional Physiological Phenomena | 4 | 2018 | 295 | 1.190 |
Why?
|
Child Nutrition Disorders | 7 | 2019 | 150 | 1.180 |
Why?
|
Sepsis | 9 | 2022 | 2587 | 1.170 |
Why?
|
Child, Preschool | 54 | 2024 | 42058 | 1.110 |
Why?
|
Infant | 54 | 2024 | 36054 | 1.070 |
Why?
|
Electric Impedance | 4 | 2017 | 754 | 0.960 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2018 | 258 | 0.880 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2018 | 1452 | 0.850 |
Why?
|
Dielectric Spectroscopy | 1 | 2022 | 30 | 0.820 |
Why?
|
Pediatrics | 9 | 2020 | 3587 | 0.800 |
Why?
|
Stomach | 2 | 2017 | 694 | 0.780 |
Why?
|
Micronutrients | 2 | 2018 | 381 | 0.770 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 109 | 0.760 |
Why?
|
Child, Hospitalized | 2 | 2023 | 182 | 0.730 |
Why?
|
Gastroparesis | 2 | 2020 | 136 | 0.730 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2020 | 362 | 0.720 |
Why?
|
Heart Defects, Congenital | 5 | 2024 | 4673 | 0.720 |
Why?
|
Rest | 6 | 2021 | 914 | 0.710 |
Why?
|
Humans | 145 | 2024 | 758381 | 0.700 |
Why?
|
Quadriceps Muscle | 2 | 2021 | 154 | 0.700 |
Why?
|
Midazolam | 1 | 2021 | 266 | 0.680 |
Why?
|
Anti-Ulcer Agents | 1 | 2020 | 112 | 0.670 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 165 | 0.650 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 101 | 0.640 |
Why?
|
Shock, Septic | 3 | 2020 | 761 | 0.640 |
Why?
|
Ascorbic Acid | 1 | 2022 | 655 | 0.630 |
Why?
|
Methylhistidines | 1 | 2017 | 35 | 0.610 |
Why?
|
Adolescent | 44 | 2024 | 87888 | 0.590 |
Why?
|
Pilot Projects | 11 | 2024 | 8554 | 0.570 |
Why?
|
Teaching Rounds | 1 | 2021 | 275 | 0.560 |
Why?
|
Length of Stay | 17 | 2021 | 6439 | 0.560 |
Why?
|
Body Mass Index | 14 | 2023 | 12876 | 0.560 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1110 | 0.560 |
Why?
|
Analgesia | 1 | 2021 | 459 | 0.560 |
Why?
|
Gastroschisis | 1 | 2018 | 99 | 0.560 |
Why?
|
Societies, Medical | 4 | 2018 | 3891 | 0.560 |
Why?
|
Absorptiometry, Photon | 3 | 2018 | 1735 | 0.550 |
Why?
|
Prospective Studies | 29 | 2022 | 54136 | 0.540 |
Why?
|
Antacids | 1 | 2016 | 94 | 0.540 |
Why?
|
Thigh | 1 | 2017 | 240 | 0.530 |
Why?
|
Hospital Mortality | 5 | 2024 | 5273 | 0.530 |
Why?
|
Haptoglobins | 3 | 2022 | 167 | 0.520 |
Why?
|
Sarcopenia | 1 | 2021 | 372 | 0.510 |
Why?
|
Breath Tests | 1 | 2017 | 297 | 0.510 |
Why?
|
Interleukin-10 | 1 | 2020 | 1174 | 0.480 |
Why?
|
Hospitalization | 7 | 2023 | 10653 | 0.470 |
Why?
|
Glycine | 1 | 2017 | 662 | 0.470 |
Why?
|
Deuterium | 1 | 2014 | 105 | 0.470 |
Why?
|
Stomach Diseases | 1 | 2015 | 133 | 0.470 |
Why?
|
Respiratory Insufficiency | 2 | 2015 | 1230 | 0.470 |
Why?
|
Body Weight | 7 | 2023 | 4603 | 0.460 |
Why?
|
Male | 64 | 2024 | 358742 | 0.450 |
Why?
|
Thoracic Surgical Procedures | 1 | 2017 | 348 | 0.450 |
Why?
|
Anthropometry | 5 | 2023 | 1347 | 0.440 |
Why?
|
Research | 2 | 2018 | 1976 | 0.430 |
Why?
|
Infant, Newborn | 23 | 2023 | 26182 | 0.430 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2016 | 278 | 0.420 |
Why?
|
Female | 66 | 2024 | 390316 | 0.420 |
Why?
|
Proteins | 4 | 2020 | 6026 | 0.420 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1162 | 0.400 |
Why?
|
Creatinine | 1 | 2017 | 1892 | 0.400 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2014 | 351 | 0.390 |
Why?
|
Home Care Services | 2 | 2015 | 647 | 0.390 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 344 | 0.390 |
Why?
|
Overnutrition | 1 | 2011 | 25 | 0.380 |
Why?
|
Cross Infection | 5 | 2022 | 1432 | 0.380 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 600 | 0.360 |
Why?
|
Algorithms | 6 | 2024 | 13959 | 0.360 |
Why?
|
Point-of-Care Systems | 3 | 2020 | 1201 | 0.360 |
Why?
|
Short Bowel Syndrome | 1 | 2014 | 353 | 0.360 |
Why?
|
Stress, Physiological | 2 | 2014 | 1398 | 0.340 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1185 | 0.340 |
Why?
|
Multiple Organ Failure | 3 | 2024 | 385 | 0.330 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1780 | 0.330 |
Why?
|
Gastrointestinal Transit | 2 | 2021 | 99 | 0.320 |
Why?
|
Protein Precursors | 3 | 2022 | 1133 | 0.310 |
Why?
|
Intensive Care Units | 5 | 2023 | 3732 | 0.310 |
Why?
|
Overweight | 2 | 2016 | 2410 | 0.310 |
Why?
|
Dietary Supplements | 2 | 2018 | 3388 | 0.300 |
Why?
|
Body Water | 2 | 2022 | 341 | 0.290 |
Why?
|
Weight Gain | 1 | 2018 | 2346 | 0.290 |
Why?
|
Pharmacokinetics | 1 | 2007 | 86 | 0.280 |
Why?
|
Infant, Newborn, Diseases | 1 | 2012 | 592 | 0.280 |
Why?
|
Retrospective Studies | 19 | 2024 | 80170 | 0.270 |
Why?
|
Program Evaluation | 1 | 2015 | 2490 | 0.270 |
Why?
|
Parenteral Nutrition, Total | 2 | 2018 | 303 | 0.270 |
Why?
|
Burns | 1 | 2017 | 1848 | 0.270 |
Why?
|
Consensus | 5 | 2020 | 3099 | 0.260 |
Why?
|
Fontan Procedure | 1 | 2012 | 791 | 0.260 |
Why?
|
DNA Methylation | 1 | 2020 | 4373 | 0.260 |
Why?
|
Uteroglobin | 1 | 2005 | 56 | 0.250 |
Why?
|
Adipose Tissue | 1 | 2017 | 3299 | 0.250 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2008 | 269 | 0.250 |
Why?
|
Feasibility Studies | 4 | 2021 | 5199 | 0.240 |
Why?
|
Postoperative Complications | 3 | 2017 | 15638 | 0.230 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2008 | 352 | 0.230 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7377 | 0.230 |
Why?
|
Reproducibility of Results | 8 | 2024 | 20052 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 77 | 0.220 |
Why?
|
Chronic Disease | 2 | 2017 | 9266 | 0.220 |
Why?
|
Guidelines as Topic | 2 | 2020 | 1386 | 0.220 |
Why?
|
Time Factors | 11 | 2021 | 39873 | 0.210 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2002 | 12 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3417 | 0.210 |
Why?
|
Ulcer | 1 | 2024 | 204 | 0.210 |
Why?
|
Obesity | 3 | 2016 | 12870 | 0.200 |
Why?
|
Rubella | 1 | 2002 | 55 | 0.200 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 494 | 0.200 |
Why?
|
Body Height | 3 | 2023 | 1567 | 0.190 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2002 | 101 | 0.190 |
Why?
|
Cholinergic Antagonists | 1 | 2021 | 164 | 0.180 |
Why?
|
Reference Values | 2 | 2021 | 4919 | 0.180 |
Why?
|
Meningitis, Meningococcal | 1 | 2000 | 44 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 2 | 2013 | 3603 | 0.180 |
Why?
|
Resuscitation | 2 | 2022 | 661 | 0.180 |
Why?
|
Meningococcal Infections | 1 | 2000 | 78 | 0.180 |
Why?
|
Skinfold Thickness | 2 | 2017 | 158 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13286 | 0.170 |
Why?
|
Polyvinyls | 1 | 2021 | 154 | 0.170 |
Why?
|
Dietary Carbohydrates | 3 | 2016 | 890 | 0.170 |
Why?
|
Heart Ventricles | 1 | 2012 | 3806 | 0.170 |
Why?
|
Cohort Studies | 8 | 2022 | 41252 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2021 | 451 | 0.170 |
Why?
|
Tachycardia, Supraventricular | 1 | 2022 | 273 | 0.170 |
Why?
|
Heart Diseases | 1 | 2012 | 2782 | 0.170 |
Why?
|
Hyperglycemia | 2 | 2020 | 1368 | 0.160 |
Why?
|
Lipoma | 1 | 2001 | 292 | 0.160 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 166 | 0.160 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 1090 | 0.160 |
Why?
|
Prevalence | 5 | 2022 | 15646 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 387 | 0.160 |
Why?
|
Esophageal Atresia | 1 | 2021 | 217 | 0.150 |
Why?
|
Republic of Korea | 1 | 2020 | 565 | 0.150 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2001 | 400 | 0.150 |
Why?
|
Nitrogen Isotopes | 1 | 2017 | 84 | 0.150 |
Why?
|
Medication Errors | 1 | 2024 | 784 | 0.150 |
Why?
|
Treatment Outcome | 10 | 2024 | 64379 | 0.150 |
Why?
|
Postoperative Period | 1 | 2022 | 1812 | 0.140 |
Why?
|
Respiration Disorders | 1 | 2000 | 367 | 0.140 |
Why?
|
High-Frequency Ventilation | 2 | 2010 | 88 | 0.140 |
Why?
|
United Arab Emirates | 1 | 2016 | 48 | 0.140 |
Why?
|
Protein-Energy Malnutrition | 1 | 2018 | 188 | 0.140 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 42 | 0.140 |
Why?
|
Ammonia | 1 | 2017 | 236 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 526 | 0.140 |
Why?
|
Malaysia | 1 | 2016 | 105 | 0.140 |
Why?
|
Indonesia | 1 | 2016 | 127 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.140 |
Why?
|
Oxygen | 2 | 2023 | 4192 | 0.140 |
Why?
|
Anesthetics, Intravenous | 1 | 1999 | 396 | 0.130 |
Why?
|
Saudi Arabia | 1 | 2016 | 209 | 0.130 |
Why?
|
Intensive Care, Neonatal | 1 | 2018 | 197 | 0.130 |
Why?
|
Thailand | 1 | 2016 | 288 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2001 | 749 | 0.130 |
Why?
|
ROC Curve | 1 | 2024 | 3563 | 0.130 |
Why?
|
Singapore | 1 | 2016 | 287 | 0.130 |
Why?
|
Brazil | 2 | 2019 | 1217 | 0.130 |
Why?
|
Feeding Methods | 1 | 2016 | 35 | 0.130 |
Why?
|
Muscles | 1 | 2021 | 1579 | 0.130 |
Why?
|
Nitrogen | 2 | 2020 | 350 | 0.130 |
Why?
|
Infant, Premature, Diseases | 1 | 2002 | 708 | 0.130 |
Why?
|
Linear Models | 3 | 2014 | 5861 | 0.130 |
Why?
|
Eating | 1 | 2022 | 1536 | 0.130 |
Why?
|
Urea | 1 | 2017 | 444 | 0.130 |
Why?
|
Angelman Syndrome | 1 | 2017 | 140 | 0.120 |
Why?
|
Tracheotomy | 1 | 2016 | 167 | 0.120 |
Why?
|
Delphi Technique | 1 | 2018 | 829 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10146 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 584 | 0.120 |
Why?
|
Infant, Small for Gestational Age | 1 | 2018 | 460 | 0.120 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4284 | 0.120 |
Why?
|
Lung Volume Measurements | 1 | 2015 | 375 | 0.120 |
Why?
|
Logistic Models | 4 | 2016 | 13276 | 0.120 |
Why?
|
Inflammation | 3 | 2024 | 10719 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 827 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2001 | 831 | 0.120 |
Why?
|
Mathematical Concepts | 1 | 2014 | 73 | 0.110 |
Why?
|
Nutrition Policy | 1 | 2017 | 470 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25953 | 0.110 |
Why?
|
Vitamins | 1 | 2022 | 1632 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1176 | 0.110 |
Why?
|
Propofol | 1 | 1999 | 606 | 0.110 |
Why?
|
Bacteremia | 1 | 2000 | 980 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 651 | 0.110 |
Why?
|
Pulmonary Ventilation | 1 | 2015 | 372 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1000 | 0.110 |
Why?
|
Australia | 1 | 2016 | 1235 | 0.110 |
Why?
|
Patient Discharge | 5 | 2023 | 3433 | 0.110 |
Why?
|
Thinness | 1 | 2016 | 490 | 0.100 |
Why?
|
Infant Nutrition Disorders | 1 | 2013 | 70 | 0.100 |
Why?
|
Acetaminophen | 1 | 2017 | 552 | 0.100 |
Why?
|
Decision Trees | 1 | 2014 | 504 | 0.100 |
Why?
|
Area Under Curve | 1 | 2017 | 1632 | 0.100 |
Why?
|
Weight Loss | 2 | 2018 | 2671 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14481 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2000 | 1054 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.100 |
Why?
|
Lactic Acid | 2 | 2020 | 1133 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 681 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1372 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1116 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14641 | 0.100 |
Why?
|
Young Adult | 6 | 2018 | 58808 | 0.090 |
Why?
|
Water-Electrolyte Balance | 1 | 2012 | 325 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39060 | 0.090 |
Why?
|
Abdomen | 1 | 2017 | 1129 | 0.090 |
Why?
|
Nutrition Disorders | 1 | 2011 | 205 | 0.090 |
Why?
|
Clinical Protocols | 2 | 2016 | 1436 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2002 | 2125 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1063 | 0.090 |
Why?
|
Bronchiolitis | 1 | 2016 | 481 | 0.090 |
Why?
|
Feces | 1 | 2017 | 1457 | 0.090 |
Why?
|
India | 1 | 2016 | 2329 | 0.090 |
Why?
|
Birth Weight | 1 | 2018 | 2097 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 377 | 0.080 |
Why?
|
Intestinal Diseases | 1 | 2014 | 505 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2551 | 0.080 |
Why?
|
United States | 7 | 2020 | 72140 | 0.080 |
Why?
|
Governing Board | 1 | 2009 | 50 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1926 | 0.080 |
Why?
|
Gestational Age | 1 | 2018 | 3565 | 0.080 |
Why?
|
Adult | 10 | 2018 | 219916 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2129 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15785 | 0.080 |
Why?
|
Quality Improvement | 1 | 2023 | 3806 | 0.080 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1718 | 0.080 |
Why?
|
Ultrasonography | 2 | 2021 | 5952 | 0.080 |
Why?
|
Perioperative Care | 1 | 2016 | 1028 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12262 | 0.080 |
Why?
|
Prognosis | 2 | 2024 | 29558 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2024 | 4761 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1888 | 0.070 |
Why?
|
Adiposity | 2 | 2014 | 1858 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3100 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3816 | 0.070 |
Why?
|
Dietary Fats | 2 | 2016 | 1991 | 0.070 |
Why?
|
Vasoconstrictor Agents | 2 | 2020 | 651 | 0.070 |
Why?
|
Fluid Therapy | 2 | 2020 | 578 | 0.070 |
Why?
|
ras Proteins | 1 | 2011 | 1049 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2497 | 0.060 |
Why?
|
Liver Diseases | 1 | 2014 | 1296 | 0.060 |
Why?
|
Respiration | 1 | 2012 | 1654 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2500 | 0.060 |
Why?
|
Probability | 1 | 2010 | 2467 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2017 | 2040 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2919 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1268 | 0.060 |
Why?
|
Blood Glucose | 2 | 2016 | 6347 | 0.060 |
Why?
|
Gastrointestinal Tract | 2 | 2024 | 830 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2371 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 931 | 0.060 |
Why?
|
Risk Factors | 5 | 2017 | 73806 | 0.060 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 161 | 0.050 |
Why?
|
Computer Simulation | 1 | 2017 | 6201 | 0.050 |
Why?
|
Prone Position | 1 | 2004 | 196 | 0.050 |
Why?
|
Lung | 2 | 2015 | 9985 | 0.050 |
Why?
|
Ventilator Weaning | 1 | 2004 | 161 | 0.050 |
Why?
|
Sri Lanka | 1 | 2002 | 92 | 0.050 |
Why?
|
London | 1 | 2002 | 234 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18125 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12096 | 0.050 |
Why?
|
Peritoneal Cavity | 1 | 2002 | 138 | 0.050 |
Why?
|
Tidal Volume | 1 | 2004 | 487 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18357 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 319 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.050 |
Why?
|
Positive-Pressure Respiration | 1 | 2004 | 636 | 0.040 |
Why?
|
Survival Rate | 2 | 2011 | 12721 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2001 | 8981 | 0.040 |
Why?
|
Hemodynamics | 2 | 2020 | 4159 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9599 | 0.040 |
Why?
|
Respiratory Aspiration | 1 | 2020 | 89 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4485 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2021 | 600 | 0.040 |
Why?
|
Diet | 1 | 2016 | 8003 | 0.040 |
Why?
|
Albumins | 1 | 2020 | 575 | 0.040 |
Why?
|
Documentation | 1 | 2023 | 892 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 986 | 0.030 |
Why?
|
Hearing | 1 | 2001 | 501 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 372 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2000 | 496 | 0.030 |
Why?
|
Travel | 1 | 2002 | 785 | 0.030 |
Why?
|
Dietetics | 1 | 2016 | 34 | 0.030 |
Why?
|
Specimen Handling | 1 | 2021 | 707 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11594 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2000 | 1829 | 0.030 |
Why?
|
Maze Learning | 1 | 2017 | 477 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 910 | 0.030 |
Why?
|
Middle East | 1 | 2016 | 230 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2007 | 3561 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2111 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2131 | 0.030 |
Why?
|
Prenatal Care | 1 | 2002 | 1129 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2210 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15225 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 747 | 0.030 |
Why?
|
Asia | 1 | 2016 | 616 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3262 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2021 | 2204 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5649 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6313 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12440 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2417 | 0.030 |
Why?
|
San Francisco | 1 | 2013 | 162 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 21273 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1185 | 0.030 |
Why?
|
Guatemala | 1 | 2013 | 159 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 981 | 0.030 |
Why?
|
Infant, Premature | 1 | 2002 | 2092 | 0.020 |
Why?
|
Prealbumin | 1 | 2013 | 222 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22006 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6852 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2002 | 3142 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 12945 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3023 | 0.020 |
Why?
|
Mental Recall | 1 | 2016 | 1208 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2002 | 4540 | 0.020 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2014 | 326 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11709 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2013 | 539 | 0.020 |
Why?
|
Serum Albumin | 1 | 2013 | 673 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6353 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 405 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3888 | 0.020 |
Why?
|
Leucovorin | 1 | 2011 | 641 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9518 | 0.020 |
Why?
|
Otolaryngology | 1 | 2016 | 685 | 0.020 |
Why?
|
Fear | 1 | 2017 | 1462 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3812 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12951 | 0.020 |
Why?
|
Vaccination | 1 | 2000 | 3356 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2359 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7980 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3671 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 824 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 588 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2686 | 0.020 |
Why?
|
Curriculum | 1 | 2020 | 3717 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7338 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 29915 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3941 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5425 | 0.020 |
Why?
|
Fluorouracil | 1 | 2011 | 1631 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2058 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7225 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1745 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6578 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1704 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6154 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10505 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4809 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1725 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14354 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7817 | 0.010 |
Why?
|
Electroencephalography | 1 | 2017 | 6187 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7403 | 0.010 |
Why?
|
Pregnancy | 1 | 2002 | 29742 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1890 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16534 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22031 | 0.010 |
Why?
|
Animals | 2 | 2021 | 167777 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11152 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23883 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81107 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9160 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 36285 | 0.010 |
Why?
|
Middle Aged | 1 | 2011 | 219560 | 0.000 |
Why?
|